Indication
Acute Hereditary Angioedema
1 clinical trial
1 product
Clinical trial
Prospective, Multicenter, Randomized, Double-blind, Parallel Group, Placebo- Controlled, Efficacy and Safety Phase 3 Study of an Intravenous Human Plasma- Derived C1 Esterase Inhibitor (C1-INH) Concentrate in Participants With Congenital C1-INH Deficiency for the Treatment and Pre-procedure Prevention of Acute Hereditary Angioedema AttacksStatus: Recruiting, Estimated PCD: 2025-12-01
Product
OCTA-C1-INH